LUC00111I2 - - Google Patents

Info

Publication number: LUC00111I2
Authority: LU; Luxembourg

Application number

LU00111C

Original Assignee

Zs Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-02-11

Filing date

2019-03-25

Publication date

2019-12-27

Family has litigation

First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=46639226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00111(I2)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-03-25Application filed by Zs Pharma IncfiledCriticalZs Pharma Inc

2019-03-29Publication of LUC00111I1publicationCriticalpatent/LUC00111I1/fr

2019-12-27Publication of LUC00111I2publicationCriticalpatent/LUC00111I2/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G25/00—Compounds of zirconium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0006—Controlling or regulating processes
- B01J19/0013—Controlling the temperature of the process
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/006—Baffles
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/0066—Stirrers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/18—Stationary reactors having moving elements inside
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/02—Processes using inorganic exchangers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/14—Base exchange silicates, e.g. zeolites
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/20—Silicates
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
- C01B39/06—Preparation of isomorphous zeolites characterised by measures to replace the aluminium or silicon atoms in the lattice framework by atoms of other elements, i.e. by direct or secondary synthesis
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
- C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
- C01B39/46—Other types characterised by their X-ray diffraction pattern and their defined composition
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/025—Silicon compounds without C-silicon linkages
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00054—Controlling or regulating the heat exchange system
- B01J2219/00056—Controlling or regulating the heat exchange system involving measured parameters
- B01J2219/00058—Temperature measurement
- B01J2219/00063—Temperature measurement of the reactants
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
- B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
- B01J2219/00094—Jackets
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00761—Details of the reactor
- B01J2219/00763—Baffles
- B01J2219/00765—Baffles attached to the reactor wall
- B01J2219/00768—Baffles attached to the reactor wall vertical
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
- C01P2004/52—Particles with a specific particle size distribution highly monodisperse size distribution
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Life Sciences & Earth Sciences (AREA)
Geology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Silicates, Zeolites, And Molecular Sieves (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

LU00111C2011-02-112019-03-25LUC00111I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161441893P	2011-02-11	2011-02-11
PCT/US2012/024727WO2012109590A2 (fr)	2011-02-11	2012-02-10	Silicate de zirconium microporeux pour traitement de l'hyperkaliémie

Publications (2)

Publication Number	Publication Date
LUC00111I1 LUC00111I1 (fr)	2019-03-29
LUC00111I2true LUC00111I2 (fr)	2019-12-27

Family

ID=46639226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU00111CLUC00111I2 (fr)	2011-02-11	2019-03-25

Country Status (32)

Country	Link
US (15)	US8802152B2 (fr)
EP (3)	EP3470370A1 (fr)
JP (3)	JP6071906B2 (fr)
KR (1)	KR101896732B1 (fr)
CN (3)	CN103534209A (fr)
AU (3)	AU2012214224B2 (fr)
BR (1)	BR112013020533A2 (fr)
CA (1)	CA2827056C (fr)
CL (2)	CL2013002337A1 (fr)
CO (1)	CO6801733A2 (fr)
CY (2)	CY1121310T1 (fr)
DK (1)	DK2673237T3 (fr)
ES (1)	ES2709004T3 (fr)
HK (1)	HK1247178A1 (fr)
HR (1)	HRP20190146T1 (fr)
HU (2)	HUE041828T2 (fr)
IL (3)	IL227907A (fr)
LT (2)	LT2673237T (fr)
LU (1)	LUC00111I2 (fr)
ME (1)	ME03294B (fr)
MX (2)	MX341822B (fr)
NL (1)	NL300976I2 (fr)
NO (1)	NO2019022I1 (fr)
PH (1)	PH12013501762B1 (fr)
PL (1)	PL2673237T3 (fr)
PT (1)	PT2673237T (fr)
RS (1)	RS58490B1 (fr)
SI (1)	SI2673237T1 (fr)
SM (1)	SMT201900037T1 (fr)
TR (1)	TR201901002T4 (fr)
WO (1)	WO2012109590A2 (fr)
ZA (1)	ZA201306240B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR201901002T4 (tr)	2011-02-11	2019-02-21	Zs Pharma Inc	Hiperkalemi tedavisine yönelik zirkonyum silikat kullanımı.
US9943637B2 (en)	2012-06-11	2018-04-17	ZS Pharma, Inc.	Microporous zirconium silicate and its method of production
CA2878832A1 (fr)*	2012-07-11	2014-01-16	ZS Pharma, Inc.	Silicate de zirconium microporeux destine au traitement de l'hyperkaliemie chez des patients hypercalcemiques et compositions ameliorees contenant du calcium destinees au traitement de l'hyperkaliemie
CN119405686A (zh)*	2012-10-08	2025-02-11	维福(国际)有限公司	治疗高血压和高血钾症的钾结合剂
CA2891053C (fr)*	2012-10-22	2020-12-01	ZS Pharma, Inc.	Silicate de zirconium microporeux pour le traitement de l'hyperkaliemie
US10695365B2 (en)	2012-10-22	2020-06-30	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
US20150359821A1 (en)*	2012-10-22	2015-12-17	ZS Pharma, Inc.	Microporous Zirconium Silicate for the Treatment of Hyperkalemia
TWI655948B (zh)*	2013-03-15	2019-04-11	美商Ｚｓ藥品公司	用於高血鉀治療之微孔矽酸鋯
JP6280636B2 (ja)*	2013-04-05	2018-02-14	ズィーエス・ファーマ，インコーポレーテッド	カリウムの低減と慢性腎臓病及び／または慢性心臓病の治療のための微多孔性ケイ酸ジルコニウム及び利尿剤
KR20160110356A (ko)*	2013-11-08	2016-09-21	제트에스 파마, 인코포레이티드	고칼륨혈증의 치료를 위한 미세다공성 규산지르코늄
EP4378577A3 (fr)*	2013-11-08	2024-10-23	ZS Pharma, Inc	Silicate de zirconium microporeux pour le traitement de l'hyperkaliémie
US20160038538A1 (en)*	2013-11-08	2016-02-11	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
CN106232126A (zh)*	2013-12-10	2016-12-14	Zs制药公司	用于治疗高钾血症、不共同施用锂的硅酸锆
US9592253B1 (en)*	2015-10-14	2017-03-14	ZS Pharma, Inc.	Extended use zirconium silicate compositions and methods of use thereof
US10668098B2 (en)	2017-07-07	2020-06-02	Hemocleanse Technology Llc	Oral sorbent for removing toxins of kidney failure combining anion and cation exchangers
WO2019092179A1 (fr)	2017-11-10	2019-05-16	Sandoz Ag	Compositions pharmaceutiques comprenant zs-9
US11524102B2 (en)	2018-07-27	2022-12-13	Fresenius Medical Care Holdings, Inc.	System for tailoring dialysis treatment based on sensed potassium concentration, patient data, and population data
SG11202109834XA (en)	2019-03-13	2021-10-28	Astrazeneca Ab	Potassium-binding agents for use in hemodialysis patients
US11484875B2 (en)	2019-07-09	2022-11-01	Uop Llc	Process for removing mercury ions from bodily fluids using titanium metallate ion exchange compositions
US11964266B2 (en)	2019-07-09	2024-04-23	Uop Llc	Process for removing cobalt, lead, cadmium and chromium ions from bodily fluids using metallate ion exchange compositions
US11577014B2 (en)	2019-07-09	2023-02-14	Uop Llc	Process for removing strontium ions from bodily fluids using metallate ion exchange compositions
WO2021199239A1 (fr)	2020-03-31	2021-10-07	興和株式会社	Composition aqueuse conditionnée
US12036528B2 (en)	2020-09-30	2024-07-16	Uop Llc	Process for removing lead ions from boldily fluids using metallate ion exchange compositions
CN112591758B (zh)*	2021-01-08	2022-10-28	景德镇皓旭陶瓷原料有限公司	一种锆渣中锆硅高效回收利用的方法
CN117446813A (zh)*	2023-10-26	2024-01-26	杭州国瑞生物科技有限公司	一种环硅酸锆钠zs-9的制备方法
CN117735564A (zh)*	2023-12-19	2024-03-22	杭州国瑞生物科技有限公司	一种环硅酸锆钠的b晶型及其制备方法与应用
CN118439624B (zh)*	2024-04-15	2025-01-24	时森海(杭州)医药科技有限公司	一种锆硅酸钠水合物及其制备方法

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE21224E (en)*		1939-10-03		Coherent zirconium silicates
US3329480A (en)	1963-10-18	1967-07-04	Union Oil Co	Crystalline zircono-silicate zeolites
US3947279A (en)	1971-12-23	1976-03-30	Owens-Illinois, Inc.	Thermally crystallizable glasses possessing precision controlled crystallization and flow properties and process of producing same
US3898318A (en)*	1973-11-14	1975-08-05	Philadelphia Quartz Co	Silicate dissolving
US4581141A (en)	1978-02-27	1986-04-08	Purdue Research Foundation	Dialysis material and method for removing uremic substances
FR2444005A1 (fr)	1978-12-15	1980-07-11	Ugine Kuhlmann	Procede industriel de fabrication en semi-continu de zeolithe a
US4374093A (en)*	1981-02-20	1983-02-15	Mobil Oil Corporation	Continuous-stream upflow zeolite crystallization apparatus
JPS6046915A (ja)*	1983-08-24	1985-03-14	Taki Chem Co Ltd	合成無定形ジルコニウム結合珪酸塩及びその製造方法
US4908832A (en)	1985-05-01	1990-03-13	Spectra-Physics, Inc.	High efficiency mode-matched solid-state laser with transverse pumping
US4943545A (en)	1987-06-08	1990-07-24	Mobil Oil Corporation	Activation of zeolites
US5032556A (en)	1989-02-21	1991-07-16	Tosoh Corporation	Preparation method for zircon powder
US5015453A (en)	1989-04-28	1991-05-14	W. R. Grace & Co.-Conn.	Crystalline group IVA metal-containing molecular sieve compositions
JP3265344B2 (ja)	1990-03-16	2002-03-11	東ソー株式会社	ジルコン粉末の合成法
JP2756174B2 (ja)*	1990-08-07	1998-05-25	神鋼パンテツク株式会社	撹拌装置
CN1070625A (zh)*	1991-11-05	1993-04-07	徐振江	提纯硅酸锆(铪)的方法
US5338527A (en)	1992-08-20	1994-08-16	Uop	Zirconium silicate composition, method of preparation and uses thereof
BR9307330A (pt)	1992-10-28	1999-06-01	Crosfield Joseph & Sons	Sílica amorfa processo para sua fabricação e composição de pasta de dentes
US5518707A (en)	1994-10-24	1996-05-21	Uop	Metallo germanates
GB9601398D0 (en)	1996-01-24	1996-03-27	Piper Edwina M	Composition
IT1283284B1 (it)	1996-03-21	1998-04-16	Eniricerche Spa	Zeolite ers-10 e procedimento per la sua preparazione
FR2750893B1 (fr)	1996-07-12	1998-10-30	Elf Aquitaine	Procede de synthese de zeolithe avec agitation homogene du milieu, dispositif et application
CA2214495C (fr)	1996-09-25	2002-02-05	Daniel L. Woodard	Composition de silicate de zirconium hydrate servant a purifier des acides nucleiques
US5888472A (en)	1997-04-08	1999-03-30	Uop Llc	Zirconium silicate molecular sieves and process using the same
US5891417A (en)	1997-04-08	1999-04-06	Uop Llc	Zirconium silicate and zirconium germanate molecular sieves and process using the same
EP0982785A4 (fr)	1997-05-12	2001-04-18	Japan Represented By Director	Separateur pour accumulateur et accumulateur electrique alcalin l'utilisant
US6007790A (en)	1998-08-13	1999-12-28	Uop Llc	Family of microporous indium silicate compositions
EP1038580B1 (fr)*	1999-03-26	2005-05-25	Uop Llc	Procédé d'adsorption d'ions ammonium utilisant des tamis moléculaires à base de silicate de zirconium et germanate de zirconium
US6099737A (en)*	1999-03-29	2000-08-08	Uop Llc	Process for removing toxins from blood using zirconium metallate or titanium metallate compositions
US6332985B1 (en)*	1999-03-29	2001-12-25	Uop Llc	Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions
US7041274B2 (en)	1999-10-22	2006-05-09	Intevep, S.A.	Aluminosilicate compositions, preparation and use
US20020061521A1 (en)*	2000-01-31	2002-05-23	Rosen Craig A.	Nucleic acids, proteins, and antibodies
AU2001243638A1 (en)*	2000-03-17	2001-10-03	Pq Holding, Inc.	Process for manufacture of zeolites and zeolite mixtures having enhanced cation exchange properties, products produced thereby, and detergent compositions formulated therewith
US6379641B1 (en)	2000-05-01	2002-04-30	Uop Llc	Microporous rare earth silicates and method of producing same
US6596254B1 (en)	2000-06-12	2003-07-22	Sandia Corporation	Niobate-based octahedral molecular sieves
JP2004502508A (ja)*	2000-07-12	2004-01-29	ユーオーピー　エルエルシー	ジルコニウム又はチタニウム微孔性組成物を用いた体液からの毒素の除去方法
AU2002242103A1 (en)*	2001-02-06	2002-08-19	Ash Medical Systems, Inc.	Monovalent-selective cation exchangers as oral sorbent therapy
US6579460B1 (en)	2001-03-13	2003-06-17	Uop Llc	Process and composition for removing toxins from bodily fluids
US6814871B1 (en)	2001-07-13	2004-11-09	Uop Llc	Process for removing pollutants from aqueous streams
ITMI20021246A1 (it)	2002-06-07	2003-12-09	Geomedical S R L	Composizioni minerali detossinanti a base di zeoliti ad elevata capacita' di scambio cationico
US6689335B1 (en)	2002-12-19	2004-02-10	Eastman Kodak Company	Silver ion sequester and release agent
WO2005041657A1 (fr)	2003-10-20	2005-05-12	Framework Therapeutics, L.L.C.	Seves moleculaires de zeolite pour l'elimination des toxines
US6984403B2 (en)	2003-12-04	2006-01-10	Pfizer Inc.	Azithromycin dosage forms with reduced side effects
CN1894029B (zh)	2003-12-15	2011-05-11	旭化成化学株式会社	多孔成形物及其生产方法
JP5000480B2 (ja)	2004-03-30	2012-08-15	レリプサ，インコーポレイテッド	イオンバランス異常の治療の方法および組成物
US8282960B2 (en)	2004-03-30	2012-10-09	Relypsa, Inc.	Ion binding compositions
US7556799B2 (en)	2004-03-30	2009-07-07	Relypsa, Inc.	Ion binding polymers and uses thereof
US8192758B2 (en)	2004-03-30	2012-06-05	Relypsa, Inc.	Ion binding compositions
US7854924B2 (en)	2004-03-30	2010-12-21	Relypsa, Inc.	Methods and compositions for treatment of ion imbalances
CN100351202C (zh)*	2004-09-03	2007-11-28	佛山欧神诺陶瓷有限公司	一种可释放负离子的健康陶瓷砖生产方法
EP2599547B1 (fr)	2004-12-28	2019-03-27	Renal Solutions, Inc.	Procédé de synthèse de particules de phosphate de zirconium
US7967984B2 (en)	2005-06-14	2011-06-28	Asahi Kasei Chemicals Corporation	Apparatus for water treatment and method of treating water
DE112006002617T5 (de)	2005-09-30	2008-08-28	Ilypsa Inc., Santa Clara	Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite
BRPI0616604A2 (pt)	2005-09-30	2012-12-25	Ilypsa Inc	mÉtodo para remover e composiÇço para seletivamente remover Íon de potÁssio do trato gastrintestinal de um mamÍfero, mÉtodo para seletivamente remover Íon de potÁssio de um meio-ambiente, composiÇço farmacÊutica, partÍcula de nécleo-envoltàrio, e, usos de uma partÍcula de nécleo-envoltàrio e de uma composiÇço farmacÊutica
US8367112B2 (en)	2006-02-28	2013-02-05	Alkermes Pharma Ireland Limited	Nanoparticulate carverdilol formulations
WO2007127390A2 (fr)	2006-04-28	2007-11-08	Biolife, L.L.C.	Matières et procédés pour le traitement de plaies
WO2008070072A2 (fr)	2006-12-01	2008-06-12	Mutual Pharmaceutical Company, Inc.	Formes, compositions de carvédilol, et leurs procédés de préparation
WO2008082087A1 (fr)	2007-01-03	2008-07-10	Insilicotech Co., Ltd	Cristal polymère de coordination comportant des structures métalliques-organiques poreuses et procédé de préparation de celui-ci
ES2304890B1 (es)*	2007-04-03	2009-10-30	Universidad De Zaragoza	Procedimiento de obtencion de esferas de titanosilicato.
EP2535320A3 (fr)	2008-02-26	2014-05-14	Corning Incorporated	Agents de finition pour verres à base de silicate
US20100104527A1 (en)*	2008-08-22	2010-04-29	Relypsa, Inc.	Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
EP2957286B1 (fr)	2008-08-22	2018-11-21	Vifor (International) Ltd.	Compositions comprenant des polymeres reticules echangeurs cationiques et utilisation dans le traitement de l'hyperkaliemie
CN101502815B (zh)*	2009-02-26	2010-09-29	江苏拜富色釉料有限公司	一种硅酸锆的制备方法
CA2765033C (fr)	2009-06-12	2020-07-14	Meritage Pharma, Inc.	Procedes de traitement de troubles gastro-intestinaux
US8865121B2 (en)	2009-06-18	2014-10-21	Basf Se	Organotemplate-free synthetic process for the production of a zeolitic material
US20120070468A1 (en)	2010-09-16	2012-03-22	Uop Llc	Removal of toxins from gastrointestinal fluids
TR201901002T4 (tr)	2011-02-11	2019-02-21	Zs Pharma Inc	Hiperkalemi tedavisine yönelik zirkonyum silikat kullanımı.
WO2012137132A1 (fr)	2011-04-08	2012-10-11	Basf Se	Procédé de production d'un catalyseur d'acylation
US10092688B2 (en)	2011-05-13	2018-10-09	Laura Jean Robinson	Medicament kit and method of use
US9527751B2 (en)	2011-11-11	2016-12-27	Basf Se	Organotemplate-free synthetic process for the production of a zeolitic material of the CHA-type structure
US20130202524A1 (en)	2012-02-06	2013-08-08	Basf Se	Iron- And Copper-Containing Zeolite Beta From Organotemplate-Free Synthesis And Use Thereof In The Selective Catalytic Reduction Of NOx
US9475041B2 (en)	2012-04-24	2016-10-25	Basf Se	Zeolitic materials and methods for their preparation using alkenyltrialkylammonium compounds
US9943637B2 (en)	2012-06-11	2018-04-17	ZS Pharma, Inc.	Microporous zirconium silicate and its method of production
CA2878832A1 (fr)	2012-07-11	2014-01-16	ZS Pharma, Inc.	Silicate de zirconium microporeux destine au traitement de l'hyperkaliemie chez des patients hypercalcemiques et compositions ameliorees contenant du calcium destinees au traitement de l'hyperkaliemie
US10695365B2 (en)	2012-10-22	2020-06-30	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
CA2891053C (fr)	2012-10-22	2020-12-01	ZS Pharma, Inc.	Silicate de zirconium microporeux pour le traitement de l'hyperkaliemie
JP6280636B2 (ja)	2013-04-05	2018-02-14	ズィーエス・ファーマ，インコーポレーテッド	カリウムの低減と慢性腎臓病及び／または慢性心臓病の治療のための微多孔性ケイ酸ジルコニウム及び利尿剤
US20160038538A1 (en)	2013-11-08	2016-02-11	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
KR20160110356A (ko)	2013-11-08	2016-09-21	제트에스 파마, 인코포레이티드	고칼륨혈증의 치료를 위한 미세다공성 규산지르코늄
US9592253B1 (en)	2015-10-14	2017-03-14	ZS Pharma, Inc.	Extended use zirconium silicate compositions and methods of use thereof

2012
- 2012-02-10TRTR2019/01002Tpatent/TR201901002T4/trunknown
- 2012-02-10RSRS20190096Apatent/RS58490B1/srunknown
- 2012-02-10CNCN201280017682.6Apatent/CN103534209A/zhactivePending
- 2012-02-10CACA2827056Apatent/CA2827056C/fractiveActive
- 2012-02-10SMSM20190037Tpatent/SMT201900037T1/itunknown
- 2012-02-10JPJP2013553608Apatent/JP6071906B2/jaactiveActive
- 2012-02-10KRKR1020137023967Apatent/KR101896732B1/koactiveActive
- 2012-02-10EPEP18195925.5Apatent/EP3470370A1/fractivePending
- 2012-02-10AUAU2012214224Apatent/AU2012214224B2/enactiveActive
- 2012-02-10PLPL12744254Tpatent/PL2673237T3/plunknown
- 2012-02-10MEMEP-2019-26Apatent/ME03294B/frunknown
- 2012-02-10PHPH1/2013/501762Apatent/PH12013501762B1/enunknown
- 2012-02-10USUS13/371,080patent/US8802152B2/enactiveActive
- 2012-02-10CNCN201810959928.0Apatent/CN109106725A/zhactivePending
- 2012-02-10PTPT12744254Tpatent/PT2673237T/ptunknown
- 2012-02-10CNCN201810963634.5Apatent/CN108969535A/zhactivePending
- 2012-02-10MXMX2013009271Apatent/MX341822B/esactiveIP Right Grant
- 2012-02-10EPEP17175312.2Apatent/EP3246287A1/fractivePending
- 2012-02-10DKDK12744254.9Tpatent/DK2673237T3/enactive
- 2012-02-10SISI201231513Tpatent/SI2673237T1/slunknown
- 2012-02-10EPEP12744254.9Apatent/EP2673237B2/fractiveActive
- 2012-02-10BRBR112013020533Apatent/BR112013020533A2/ptnot_activeApplication Discontinuation
- 2012-02-10HUHUE12744254Apatent/HUE041828T2/huunknown
- 2012-02-10ESES12744254Tpatent/ES2709004T3/esactiveActive
- 2012-02-10WOPCT/US2012/024727patent/WO2012109590A2/fractiveApplication Filing
- 2012-02-10LTLTEP12744254.9Tpatent/LT2673237T/ltunknown
- 2012-02-10HRHRP20190146TTpatent/HRP20190146T1/hrunknown
2013
- 2013-08-09MXMX2016011293Apatent/MX354456B/esunknown
- 2013-08-11ILIL227907Apatent/IL227907A/enactiveProtection Beyond IP Right Term
- 2013-08-12CLCL2013002337Apatent/CL2013002337A1/esunknown
- 2013-08-19ZAZA2013/06240Apatent/ZA201306240B/enunknown
- 2013-08-28COCO13204047Apatent/CO6801733A2/esnot_activeApplication Discontinuation
- 2013-09-25USUS14/036,489patent/US8808750B2/enactiveActive
2014
- 2014-03-26USUS14/226,279patent/US9457050B2/enactiveActive
- 2014-07-01USUS14/321,678patent/US20140377560A1/ennot_activeAbandoned
- 2014-07-01USUS14/321,659patent/US9844567B2/enactiveActive
- 2014-07-01USUS14/321,634patent/US9662352B2/enactiveActive
- 2014-08-01USUS14/450,126patent/US20140342017A1/ennot_activeAbandoned
2015
- 2015-03-31USUS14/659,043patent/US20150196592A1/ennot_activeAbandoned
- 2015-04-21USUS14/692,287patent/US10413569B2/enactiveActive
- 2015-08-13USUS14/826,011patent/US10398730B2/enactiveActive
- 2015-08-13USUS14/826,038patent/US9861658B2/enactiveActive
2016
- 2016-03-22ILIL244704Apatent/IL244704A/enactiveIP Right Grant
- 2016-05-13CLCL2016001166Apatent/CL2016001166A1/esunknown
- 2016-06-17AUAU2016204124Apatent/AU2016204124B2/enactiveActive
- 2016-09-01USUS15/254,688patent/US10335432B2/enactiveActive
- 2016-11-01JPJP2016214142Apatent/JP6251354B2/jaactiveActive
- 2016-12-26JPJP2016250523Apatent/JP2017105706A/jaactivePending
2017
- 2017-10-15ILIL255025Apatent/IL255025A0/enunknown
- 2017-10-27AUAU2017251826Apatent/AU2017251826A1/ennot_activeAbandoned
- 2017-11-08USUS15/807,352patent/US20180125884A1/ennot_activeAbandoned
2018
- 2018-05-21HKHK18106615.2Apatent/HK1247178A1/enunknown
2019
- 2019-01-24CYCY20191100098Tpatent/CY1121310T1/elunknown
- 2019-03-19CYCY2019015Cpatent/CY2019015I2/elunknown
- 2019-03-25LULU00111Cpatent/LUC00111I2/frunknown
- 2019-03-27NLNL300976Cpatent/NL300976I2/nlunknown
- 2019-04-02HUHUS1900019Cpatent/HUS1900019I1/huunknown
- 2019-04-05LTLTPA2019010Cpatent/LTC2673237I2/ltunknown
- 2019-05-02NONO2019022Cpatent/NO2019022I1/nounknown
2020
- 2020-04-16USUS16/850,468patent/US11406662B2/enactiveActive
2022
- 2022-06-30USUS17/855,758patent/US20230181631A1/ennot_activeAbandoned

Also Published As

Publication number	Publication date
CY2019015I1 (el)	2020-05-29
JP2017105706A (ja)	2017-06-15
SMT201900037T1 (it)	2019-02-28
ZA201306240B (en)	2018-12-19
PT2673237T (pt)	2019-02-01
IL227907A0 (en)	2013-09-30
US10413569B2 (en)	2019-09-17
DK2673237T3 (en)	2019-02-18
EP2673237A2 (fr)	2013-12-18
JP6251354B2 (ja)	2017-12-20
AU2016204124B2 (en)	2017-08-31
CO6801733A2 (es)	2013-11-29
ES2709004T3 (es)	2019-04-12
AU2012214224A1 (en)	2013-09-05
IL255025A0 (en)	2017-12-31
CA2827056C (fr)	2020-07-14
CY1121310T1 (el)	2020-05-29
AU2012214224B2 (en)	2016-03-17
HUE041828T2 (hu)	2019-05-28
US20140044785A1 (en)	2014-02-13
HK1247178A1 (en)	2018-09-21
HUS1900019I1 (hu)	2019-05-28
NL300976I2 (nl)	2019-08-27
MX341822B (es)	2016-09-05
US8802152B2 (en)	2014-08-12
US9662352B2 (en)	2017-05-30
EP2673237B2 (fr)	2025-10-01
US20150004235A1 (en)	2015-01-01
LUC00111I1 (fr)	2019-03-29
US10335432B2 (en)	2019-07-02
BR112013020533A2 (pt)	2016-10-18
AU2017251826A1 (en)	2017-11-16
US9844567B2 (en)	2017-12-19
JP2017052694A (ja)	2017-03-16
MX2013009271A (es)	2014-01-23
US9861658B2 (en)	2018-01-09
EP3246287A1 (fr)	2017-11-22
US9457050B2 (en)	2016-10-04
PH12013501762B1 (en)	2019-02-06
WO2012109590A2 (fr)	2012-08-16
CL2013002337A1 (es)	2014-02-14
US20150225249A1 (en)	2015-08-13
US20140377560A1 (en)	2014-12-25
WO2012109590A9 (fr)	2013-04-11
AU2016204124A1 (en)	2016-07-14
CL2016001166A1 (es)	2017-01-20
CN108969535A (zh)	2018-12-11
WO2012109590A3 (fr)	2012-10-18
CY2019015I2 (el)	2020-05-29
US10398730B2 (en)	2019-09-03
KR20140033007A (ko)	2014-03-17
IL244704A (en)	2017-10-31
US20120213847A1 (en)	2012-08-23
US20230181631A1 (en)	2023-06-15
US20150196592A1 (en)	2015-07-16
EP2673237A4 (fr)	2014-12-31
US20180125884A1 (en)	2018-05-10
KR101896732B1 (ko)	2018-09-07
US20150342988A1 (en)	2015-12-03
US20160367598A1 (en)	2016-12-22
US8808750B2 (en)	2014-08-19
EP2673237B1 (fr)	2018-11-07
LTC2673237I2 (lt)	2024-05-27
MX354456B (es)	2018-03-06
LT2673237T (lt)	2019-05-10
US20140287060A1 (en)	2014-09-25
TR201901002T4 (tr)	2019-02-21
US20200390805A1 (en)	2020-12-17
PL2673237T3 (pl)	2019-04-30
US20140342017A1 (en)	2014-11-20
US20160000825A1 (en)	2016-01-07
IL227907A (en)	2016-04-21
CN103534209A (zh)	2014-01-22
NL300976I1 (nl)	2019-04-03
US20140377359A1 (en)	2014-12-25
JP2014506556A (ja)	2014-03-17
PH12013501762A1 (en)	2013-10-14
NO2019022I1 (no)	2019-05-02
ME03294B (fr)	2019-07-20
CN109106725A (zh)	2019-01-01
EP3470370A1 (fr)	2019-04-17
LTPA2019010I1 (lt)	2019-05-10
RS58490B1 (sr)	2019-04-30
JP6071906B2 (ja)	2017-02-01
HRP20190146T1 (hr)	2019-03-22
SI2673237T1 (sl)	2019-03-29
US11406662B2 (en)	2022-08-09
CA2827056A1 (fr)	2012-08-16
IL244704A0 (en)	2016-04-21

Publication	Publication Date	Title
BR112013022641A2 (fr)	2017-09-21
BR112013031251A2 (fr)	2017-09-12
BR112013027245A2 (fr)	2017-01-03
AP3853A (fr)	2016-09-30
BR112013026905A2 (fr)	2017-01-03
BR112013023185A2 (fr)	2017-01-03
BR112013022995A2 (fr)	2012-09-13
BR112013027830A2 (fr)	2017-01-03
BR112013017670A2 (fr)	2017-08-15
BR112013027452A2 (fr)	2017-01-03
BR112013028733A2 (fr)	2017-08-29
BR112013027121A2 (fr)	2017-01-03
AP2016009466A0 (fr)	2016-09-30
BR112013031556A2 (fr)	2017-08-29
BR112013024588A2 (fr)	2017-01-03
BR112013026790A2 (fr)	2017-05-02
BR112013032368A2 (fr)	2017-01-03
BR112013032377A2 (fr)	2017-01-03
BR112013032380A2 (fr)	2017-01-03
BR112013027836A2 (fr)	2017-01-03
BR112013018949A2 (fr)	2017-09-12
BR112013026895A2 (fr)	2017-01-03
BR112013027761A2 (fr)	2017-01-03
BR112013021637A2 (fr)	2012-11-01
BR112013023266A2 (fr)	2017-09-12

Movatterモバイル変換